e7777
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
5
Phase 3
2
Phase 4
0
Earliest trial started Mar 1, 2011 (NCT01355783)
Timeline
Indications
Studied for
- Carcinoma, Ovarian Epithelial · Phase 1/Phase 2
- Lymphoma, B-Cell · Phase 1/Phase 2
- Lymphoma, Follicular · Phase 1/Phase 2
- Lymphoma, Large B-Cell, Diffuse · Phase 1/Phase 2
- Lymphoma, Large-Cell, Immunoblastic · Phase 1/Phase 2
- Lymphoma, T-Cell · Phase 3
- Lymphoma, T-Cell, Cutaneous · Phase 2
- Lymphoma, T-Cell, Peripheral · Phase 3
Mechanism of action
Chemistry & pharmacology
- Payload
- diphtheria toxin
Oral
No
Parenteral
No
Topical
No
Also known as
- e7777
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05200559 | Phase 1/Phase 2 (Phase 2) | Sep 30, 2022 | Dr. Reddy's Laboratories, University of Pittsburgh |
| NCT04855253 | Phase 1/Phase 2 (Phase 2) | Jun 9, 2021 | University of Minnesota |
| NCT01871727 | Phase 3 | May 9, 2016 | Eisai |
| NCT02676778 | Phase 2 | Mar 1, 2016 | Eisai |
| NCT01355783 | Phase 3 | Mar 1, 2011 | Eisai |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eisai | For profit | 3 | 3 | 2 | 2011 |
| Dr. Reddy's Laboratories | For profit | 1 | 0 | 1 | 2022 |
| University of Minnesota | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Pittsburgh | Academic/Hospital | 1 | 1 | 1 | 2022 |
4 organizations
Page 1 / 1